Dirk Garmann is a seasoned professional in pharmacometrics, serving as the Head Pharmacometrics at Bayer since 2015, where they lead a team focused on population modeling and simulation across the pharmaceutical development portfolio, particularly in oncology and cardiovascular domains. Previously, Garmann held roles as Senior Modeling & Simulation Expert and Head of Quantitative Pharmacology at Bayer, and as a Clinical Pharmacokineticist M&S Specialist at UCB Pharma/Schwarz Biosciences, along with a Clinical Scientific Expert position at Merz Pharmaceuticals. Garmann has extensive experience in guiding drug development processes and conducting significant pharmacometric studies across various therapeutic areas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices